| HOME >> MEDICINE >> TECHNOLOGY |
20112012
2011Net sales
$3,474,231
$3,550,535$8,044,756
$6,767,734Cost of goods sold
1,626,965
1,281,5613,470,864
2,734,968Gross profit
1,847,266
2,268,9744,573,892
4,032,766Selling expenses
1,545,585
1,194,0453,004,149
2,374,297General and administrative expenses
1,092,726
1,082,3852,135,058
2,250,205Research and development expenses
366,257
303,702763,388
613,676Total operating expenses
3,004,568
2,580,1325,902,595
5,238,178Loss from operations
(1,157,302)
(311,158)(1,328,703)
(1,205,412)Total other income
502,387
331,871713,804
427,099(Loss)/income from continuing operations before income taxes
(654,915)
20,713(614,899)
(778,313)Income tax expense/(benefit)
2,329
(207,233)3,829
(202,273)Net (loss)/income from continuing operations
(657,244)
227,946(618,728)
(576,040)Discontinued operations:Gain from sale of discontinued operations net of tax expense of $0,$532,268, $0 and $532,268, respectively
0
918,3580
918,358Net income (loss) from discontinued operations, net of a tax benefit of $0, $130,517, $0 and a tax benefit of $130,517, respectively
3,475
(126,225)9,793
(206,181)Net income from discontinued operations
3,475
792,1339,793
712,177Net (loss)/income
($653,769)
$1,020,079($608,935)
$136,137Net (loss)/income per share from continuing operations-Basic
($0.09)
$0.03($0.09)
($0.08)Net income per share from discontinued operations-Basic
0.00
0.110.00
0.10Net (loss)/income per share-Basic
($0.
'/>"/>
| SOURCE Misonix, Inc. Copyright©2012 PR Newswire. All rights reserved |